Tumor cells rapidly divide by usurping a metabolic trick from normal cell development.
Advertisement
The Scientist
Most Recent
Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.
The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.
Fecal transplants outcompeted traditional antibiotics at curing a deadly intestinal infection.
By analyzing a collection of 24 genetic variations, researchers are able to predict the hair and eye color of long-dead humans.
Scientists use virus-free gene therapy on patient-derived stem cells to repair spinal muscular atrophy in mice.
Researchers and biotech companies are bringing a universal flu vaccine closer to reality.
Resource-limited countries are in desperate need of better diagnostic tests for life-threatening illnesses.
Transplanting synthetic stool made of beneficial microbes cures deadly diarrheal infections in two patients.
Researchers uncover weekly and monthly rhythms of sodium retention and excretion in participants of space simulations.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
